A Study of Sintilimab Combined With Chemotherapy for Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma
Clinical trial NCT06463834 · RECRUITING
Trial details
- NCT number
- NCT06463834
- Sponsor
- Fujian Cancer Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-20
- Primary completion
- 2025-03-19
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.